A single blood test measuring p-tau217 protein can predict when cognitively unimpaired individuals will develop Alzheimer's symptoms, with a margin of error of 3-4 years, potentially accelerating clinical trials.
The Preeclampsia Foundation released a new educational resource to help OB-GYNs navigate predictive and diagnostic biomarker testing for hypertensive disorders of pregnancy, covering FDA-cleared tests from Thermo Fisher Scientific and Roche Diagnostics.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07226895 |
A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis |
RECRUITING | PHASE1/PHASE2 |
| NCT07122700 |
Evaluation of Non-Invasive Tests for Metabolic Liver Disease |
RECRUITING | |
| NCT06581861 |
PREVENT ALL ALS Study |
RECRUITING | |
| NCT06578195 |
ASSESS ALL ALS Study |
RECRUITING | |
| NCT06457789 |
Assessment of PET Tracers to Evaluate T Cell Change and Activation in Relation to Immunotherapy Treatment Response in Non-Small Cell Lung Cancer |
RECRUITING | NA |
| NCT05081427 |
Non-invasive Biomarkers of Metabolic Liver Disease (NIMBLE) Study 1.2 |
COMPLETED | |
| NCT04828551 |
Noninvasive Biomarkers of Metabolic Liver Disease 1.1 |
COMPLETED | NA |
| NCT02789241 |
Dose-Related Inflammatory Effects of Intravenous Endotoxin in Humans |
COMPLETED | PHASE1 |
| NCT02443922 |
Dynamic Responsiveness of Insulin Secretory Parameters To Sitagliptin and Glimeperide Administration in Type 2 DM |
UNKNOWN | NA |
| NCT02441426 |
Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health and Development |
UNKNOWN |
